sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
20-Sep-2014 02:05
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 251-275 out of 885.

<< < 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 > >>

Public Release: 20-Mar-2014
NIH grants up to $28 million to group led by Scripps Research for work on ebola treatment
The National Institutes of Health has awarded a five-year grant of up to $28 million to establish a new center for excellence to find an antibody 'cocktail' to fight the deadly Ebola virus. The project, which involves researchers from 15 institutions, will be led by Erica Ollmann Saphire, professor at the Scripps Research Institute.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 20-Mar-2014
Optical Materials Express
Shrink wrap used to enhance detection of infectious disease biomarkers
A new nanotechnology method -- employing common, everyday shrink wrap -- may make highly sensitive, extremely low-cost diagnosis of infectious disease agents possible. The new technique, described in a paper published today in the Optical Society's journal Optical Materials Express, offers a way to significantly boost the signal of fluorescent markers used in biosensing, by depositing a combination of metals onto shrink wrap.

Contact: Lyndsay Meyer
lmeyer@osa.org
202-416-1435
The Optical Society

Public Release: 20-Mar-2014
Blood
Low levels of oxygen, nitric oxide worsen sickle cell disease
Low levels of both oxygen and the powerful blood vessel dilator nitric oxide appear to have an unfortunate synergy for patients with sickle cell disease, researchers report.
National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 20-Mar-2014
Weak spot of parasitic worms attacked to cure tropical diseases
Researchers are developing new drug treatments to tackle river blindness and elephantiasis, which affect up to 150 million people across the world.
Global Health Innovative Technology Fund

Contact: Jamie Brown
jamie.brown@liverpool.ac.uk
44-151-794-2248
University of Liverpool

Public Release: 20-Mar-2014
Journal of the Pediatric Infectious Diseases Society
Antibiotic-resistant bacteria among children in the United States on the rise
Infections caused by a specific type of antibiotic-resistant bacteria are on the rise in US children, according to new study published in the Journal of the Pediatric Infectious Diseases Society. While still rare, the bacteria are increasingly found in children of all ages, especially those 1-5 years old, raising concerns about dwindling treatment options.

Contact: Nancy DiFiore
nancy_difiore@rush.edu
312-942-5159
Rush University Medical Center

Public Release: 20-Mar-2014
Journal of the Pediatric Infectious Diseases Society
Among US children, more infections caused by drug-resistant bacteria
Infections caused by a concerning type of antibiotic-resistant bacteria are on the rise in US children, according to a new study published in the Journal of the Pediatric Infectious Diseases Society and available online. Although still uncommon, the bacteria are increasingly found in children of all ages, especially those one to five years old, raising concerns about dwindling treatment options.

Contact: Terri Christene Phillips
cphillips@idsociety.org
703-299-9865
Pediatric Infectious Diseases Society

Public Release: 19-Mar-2014
Scientist receives NIH grant to find cure for infectious disease
A Clemson University scientist was awarded a two-year, $147,157 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to find a cure for an infectious disease.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Lesly A. Temesvari
ltemesv@clemson.edu
864-656-6387
Clemson University

Public Release: 19-Mar-2014
Science Translational Medicine
Past HIV vaccine trials reveal new path to success
A multi-national research team led by Duke Medicine scientists has identified a subclass of antibodies associated with an effective immune response to an HIV vaccine.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 19-Mar-2014
American Chemical Society 247th National Meeting & Exposition
No-refrigeration, spray vaccine could curb diseases in remote areas
A new kind of single-dose vaccine that comes in a nasal spray and doesn't require refrigeration could dramatically alter the public health landscape -- get more people vaccinated around the world and address the looming threats of emerging and re-emerging diseases. Researchers presented the latest design and testing of these 'nanovaccines' at the 247th National Meeting & Exposition of the American Chemical Society, the world's largest scientific society.

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society

Public Release: 17-Mar-2014
Journal of Biological Chemistry
New therapeutic target identified for acute lung injury
A bacterial infection can throw off the equilibrium between two key proteins in the lungs and put patients at risk for a highly lethal acute lung injury, researchers report.
National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 14-Mar-2014
PLOS ONE
School sick days could be reduced with safe drinking water
Providing free drinking water in schools could be key to helping people in developing countries lift themselves out of poverty according to research from the University of East Anglia. New research shows that schools providing clean water report fewer children off sick. It is the first study to investigate whether providing drinking water in schools can reduce absenteeism.

Contact: Lisa Horton
l.horton@uea.ac.uk
44-160-359-2764
University of East Anglia

Public Release: 13-Mar-2014
Innovative solar-powered toilet developed by CU-Boulder ready for India unveiling
A revolutionary University of Colorado Boulder toilet fueled by the sun that is being developed to help some of the 2.5 billion people around the world lacking safe and sustainable sanitation will be unveiled in India this month.
Bill and Melinda Gates Foundation

Contact: Karl Linden
karl.linden@colorado.edu
303-502-0188
University of Colorado at Boulder

Public Release: 12-Mar-2014
Second largest research award at Notre Dame fights malaria and dengue fever
Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -- spatial repellency -- for the prevention of two important mosquito-borne diseases: malaria and dengue fever.
Bill and Melinda Gates Foundation

Contact: william gilroy
gilroy.6@nd.edu
574-631-4127
University of Notre Dame

Public Release: 11-Mar-2014
Novel vaccine trial design aims to answer key TB questions
Aeras today announced the initiation of the first randomized, controlled tuberculosis vaccine trial designed to study prevention of Mycobacterium tuberculosis infection by vaccination.

Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras

Public Release: 9-Mar-2014
Eye health experts come together to boost fight against avoidable blindness
On Commonwealth Day, a new £7.1 million grant has established the Commonwealth Eye Health Consortium. Coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine, the Consortium will pursue vital research into conditions such as diabetic retinopathy which leave millions without sight, and will build capacity across the Commonwealth to tackle avoidable blindness and provide quality care to those affected or at risk.
The Queen Elizabeth Diamond Jubilee Trust

Contact: Katie Steels
press@lshtm.ac.uk
44-020-792-92802
London School of Hygiene & Tropical Medicine

Public Release: 7-Mar-2014
PLOS ONE
Education 'protects' poor women from fattening effects of rising wealth
Obesity levels among women in low- and middle-income countries tend to rise in line with wealth as they purchase more energy-dense foods, but a new UCL study suggests that more educated consumers make better food choices that mitigate this effect. The study showed that in middle-income countries, obesity levels among women with secondary or higher education are 14-19 percent lower than less-educated women of similar wealth.

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-077-475-65056
University College London

Public Release: 6-Mar-2014
Science
Warmer temperatures push malaria to higher elevations
Researchers have debated for more than two decades the likely impacts, if any, of global warming on the worldwide incidence of malaria, a mosquito-borne disease that infects more than 300 million people each year.

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan

Public Release: 6-Mar-2014
PLOS Pathogens
Drug protects mice against malaria brain damage, raises levels of BDNF in humans
Cerebral malaria is a serious complication of infection with the malaria parasite, affecting approximately one in a thousand children in areas where malaria is common. Many of the patients die, and among those who survive, about a third have lasting cognitive and neurological disabilities, including epilepsy and learning disorders. A study published on March 6 in PLOS Pathogens shows that a known drug can prevent brain damage in a cerebral malaria mouse model and eliminate subsequent neurological deficits.

Contact: Lena Serghides
lena.serghides@utoronto.ca
647-230-7540
PLOS

Public Release: 4-Mar-2014
21st Conference on Retroviruses and Opportunistic Infections
Two studies advance HIV prevention options for women
Two early clinical studies of novel HIV prevention products for women -- the first combination antiretroviral vaginal ring and a vaginal film -- show the products to be safe and open the door to product improvements that could expand options for women-initiated prevention tools. The results of both studies were presented today at the 21st Conference on Retroviruses and Opportunistic Infections.

Contact: Holly Seltzer
hseltzer@ipmglobal.org
301-608-4277
International Partnership for Microbicides (IPM)

Public Release: 4-Mar-2014
Global Public Health
Fighting against HIV in the Central African Republic -- the importance of perseverance
According to Pierre-Marie David of the University of Montreal's Faculty of Pharmacy, stock-outs of antiretroviral drugs in recent years in the Central African Republic have had a dramatic impact on the health of HIV-infected people. These shortages have also created mistrust among patients toward the political and medical actors responsible for the fight against HIV/AIDS.
Méos, SIDAction

Contact: William Raillant-Clark
w.raillant-clark@umontreal.ca
514-566-3813
University of Montreal

Public Release: 3-Mar-2014
New constipation treatment under study for Parkinson's patients
Constipation can be another uncomfortable problem for patients with Parkinson's disease that standard treatment won't relieve, researchers say.
Rhythm

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 3-Mar-2014
Nature
Novel drug treatment protects primates from deadly Marburg virus
For the first time, scientists have demonstrated the effectiveness of a small-molecule drug in protecting nonhuman primates from the lethal Marburg virus. Their work, published online in the journal Nature, is the result of a continuing collaboration between Army scientists and industry partners that also shows promise for treating a broad range of other viral diseases.
Joint Science and Technology Office for Chemical and Biological Defense, Defense Threat Reduction Agency

Contact: Caree Vander Linden
Caree.VanderLinden@us.army.mil
US Army Medical Research Institute of Infectious Diseases

Public Release: 3-Mar-2014
Nature
New research on potent HIV antibodies has opened up possibilities
The discovery of how a KwaZulu-Natal woman's body responded to her HIV infection by making potent antibodies (called broadly neutralizing antibodies, because they are able to kill multiple strains of HIV from across the world), was reported today by the CAPRISA consortium of AIDS researchers jointly with scientists from the United States.

Contact: Vivienne Rowland
Vivienne.Rowland@wits.ac.za
27-011-717-1017
University of the Witwatersrand

Public Release: 3-Mar-2014
Europe is joining forces against neglected parasitic diseases
The international consortium A-PARADDISE (Anti-Parasitic Drug Discovery in Epigenetics), coordinated by Inserm, has just obtained funds of €6 million from the European Commission to conduct large-scale testing of innovative therapies against four neglected parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria. The researchers have a common objective: to develop new drugs against the parasites that cause these diseases.
European Commission

Contact: Raymond Pierce
Raymond.Pierce@pasteur-lille.fr
33-320-877-783
INSERM (Institut national de la santé et de la recherche médicale)

Public Release: 28-Feb-2014
Journal of Virology
Light zaps viruses: How photosensitization can stop viruses from infecting cells
Researchers find evidence that photosensitizing a virus's membrane covering can inhibit its ability to enter cells and potentially lead to the development of stronger, cheaper medications to fight a host of tough viruses.
National Institutes of Health, Fundação para a Ciência e a Tecnologia

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles Health Sciences

Showing releases 251-275 out of 885.

<< < 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 > >>